These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11868866)

  • 21. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes and the endocrine heart.
    Christoffersen C; Hunter I; Jensen AL; Goetze JP
    Eur Heart J; 2007 Oct; 28(20):2427-9. PubMed ID: 17872916
    [No Abstract]   [Full Text] [Related]  

  • 23. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study.
    Alssema M; Dekker JM; Kuivenhoven JA; Nijpels G; Teerlink T; Scheffer PG; Diamant M; Stehouwer CD; Bouter LM; Heine RJ
    Diabet Med; 2007 Feb; 24(2):117-23. PubMed ID: 17257272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
    Elias AN; Eng S
    Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of antithrombin III activity in children with diabetes mellitus].
    Maak B; Kauf E; Spahn U; Hobert I
    Kinderarztl Prax; 1987 Oct; 55(10):499-504. PubMed ID: 3430973
    [No Abstract]   [Full Text] [Related]  

  • 26. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.
    Mackness B; McElduff P; Mackness MI
    J Intern Med; 2005 Oct; 258(4):363-8. PubMed ID: 16164576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculation of coronary risk in Type II diabetes.
    Durrington P
    Clin Sci (Lond); 2001 Dec; 101(6):681-2. PubMed ID: 11724656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic aspects of diabetes mellitus and diabetic angiopathies].
    Efimov AS
    Vestn Akad Med Nauk SSSR; 1986; (9):49-54. PubMed ID: 3788275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immune reactions and vascular complications in diabetes mellitus].
    Triolo G
    Recenti Prog Med; 1987 Jan; 78(1):36-8. PubMed ID: 3589119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

  • 34. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
    J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.
    Akbay E; Yetkin I; Ersoy R; Kulaksizoğlu S; Törüner F; Arslan M
    Diabetes Nutr Metab; 2004 Dec; 17(6):331-5. PubMed ID: 15887626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphofunctional changes in the erythrocytes in diabetes mellitus].
    Efimov AS; Pleshanov EV; Gogina IF
    Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary prevention of type 2 diabetes].
    Hanefeld M
    Dtsch Med Wochenschr; 2002 May; 127(18):951-2. PubMed ID: 11987014
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid composition of thrombocytes in diabetes mellitus depending on the degree of microangiopathy].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov VZ
    Probl Endokrinol (Mosk); 1987; 33(4):20-3. PubMed ID: 3658945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.
    Forst T; Standl E; Hohberg C; Konrad T; Schulze J; Strotmann HJ; Lübben G; Pahler S; Bachinger A; Langenfeld M; Pfützner A
    Diabet Med; 2004 Oct; 21(10):1149-53. PubMed ID: 15384965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.
    Krentz AJ; Clough G; Byrne CD
    Diabetes Obes Metab; 2007 Nov; 9(6):781-91. PubMed ID: 17924862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.